Library / Laws / 115th Congress / House Bills / H.R. 2051
H.R. 2051
To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2017-04-06 | 14.5K | ⠃⠗⠋ |